NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Epidemiological Study of Treatment Approaches in AChR-Antibody Positive Generalized Myasthenia Gravis in Russia

RecruitingN/A

Sponsor: AstraZeneca

Conditions: Rare Diseases, Generalized Myasthenia Gravis (gMG)

Countries: Russia

This is a multicenter, non-interventional, retrospective-prospective, single-arm observational study designed to describe real-world treatment approaches and clinical outcomes among adults with acetylcholine receptor (AChR) antibody-positive generalized myasthenia gravis (gMG) in routine clinical practice in Russia.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

1. Adults (≥18 years) diagnosed with generalized MG positive for acetylcholine receptor (AChR) antibodies.
2. Provision of signed and dated written informed consent.

Exclusion Criteria:

1. Participants currently enrolled in clinical studies for treatment of gMG.
2. Ocular MG only.

Locations (7)

Kazan', Russia
Moscow, Russia
Novosibirsk, Russia
Rostov-on-Don, Russia
Saint Petersburg, Russia
Samara, Russia
Ufa, Russia